SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601830-23-000021
Filing Date
2023-05-08
Accepted
2023-05-08 08:00:31
Documents
13
Period of Report
2023-05-08
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20230508.htm   iXBRL 8-K 39873
2 EX-99.1 ex991cyclicaandvalencepres.htm EX-99.1 20087
  Complete submission text file 0001601830-23-000021.txt   206948

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20230508.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20230508_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20230508_pre.xml EX-101.PRE 13045
7 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20230508_htm.xml XML 10606
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 23895904
SIC: 2836 Biological Products, (No Diagnostic Substances)